Cargando…
Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the fourth cause of cancer-related mortality worldwide. While many targeted therapies have been developed, the majority of HCC tumors do not harbor clinically actionable mutations. Protein-level aberrations, especially those not evident at the genomic level, present...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006883/ https://www.ncbi.nlm.nih.gov/pubmed/35433463 http://dx.doi.org/10.3389/fonc.2022.814120 |